Natixis Asset Management Boosted Thermo Fisher Scientific INC (TMO) Holding by $19.71 Million

June 13, 2018 - By Migdalia James

Thermo Fisher Scientific Inc. (NYSE:TMO) LogoInvestors sentiment decreased to 0.86 in 2018 Q1. Its down 0.05, from 0.91 in 2017Q4. It is negative, as 42 investors sold TMO shares while 444 reduced holdings. 119 funds opened positions while 301 raised stakes. 331.98 million shares or 1.09% less from 335.65 million shares in 2017Q4 were reported. Efg Asset (Americas) reported 10,592 shares stake. Amer Research & holds 0.2% or 2,965 shares in its portfolio. Amalgamated Bank holds 0.29% or 53,657 shares. United Kingdom-based Veritas Inv Llp has invested 10.13% in Thermo Fisher Scientific Inc. (NYSE:TMO). Bancorporation Of Montreal Can reported 0.06% in Thermo Fisher Scientific Inc. (NYSE:TMO). Soros Fund Limited Liability reported 193,000 shares. Bp Public Ltd Co reported 0.34% of its portfolio in Thermo Fisher Scientific Inc. (NYSE:TMO). Jennison Lc holds 145,191 shares. Jp Marvel Investment Advsrs Limited Liability holds 3.14% or 49,334 shares in its portfolio. Capital One National Association invested 0.17% in Thermo Fisher Scientific Inc. (NYSE:TMO). Alleghany De owns 1.32% invested in Thermo Fisher Scientific Inc. (NYSE:TMO) for 240,000 shares. Eads Heald Invest Counsel owns 1.53% invested in Thermo Fisher Scientific Inc. (NYSE:TMO) for 11,667 shares. 33,315 are owned by Duncker Streett &. Stevens Capital Mngmt L P, Pennsylvania-based fund reported 10,933 shares. Lombard Odier Asset (Switzerland) Sa owns 52,027 shares.

Since December 15, 2017, it had 0 insider buys, and 9 selling transactions for $28.13 million activity. 1,000 Thermo Fisher Scientific Inc. (NYSE:TMO) shares with value of $209,796 were sold by Parrett William G. 6,000 shares were sold by Durbin Patrick M, worth $1.31 million. HARRIS C MARTIN sold $44,174 worth of stock or 206 shares. Williamson Stephen sold 2,500 shares worth $530,000. Herrema Gregory J. sold 33,327 shares worth $7.32M.

Natixis Asset Management increased its stake in Thermo Fisher Scientific Inc. (TMO) by 59.57% based on its latest 2018Q1 regulatory filing with the SEC. Natixis Asset Management bought 95,690 shares as the company’s stock declined 0.20% with the market. The institutional investor held 256,338 shares of the industrial machinery and components company at the end of 2018Q1, valued at $52.92 million, up from 160,648 at the end of the previous reported quarter. Natixis Asset Management who had been investing in Thermo Fisher Scientific Inc. for a number of months, seems to be bullish on the $87.03B market cap company. The stock decreased 0.75% or $1.64 during the last trading session, reaching $216.31. About 857,310 shares traded. Thermo Fisher Scientific Inc. (NYSE:TMO) has risen 23.57% since June 13, 2017 and is uptrending. It has outperformed by 11.00% the S&P500.

More news for Thermo Fisher Scientific Inc. (NYSE:TMO) were recently published by: Seekingalpha.com, which released: “Thermo Fisher Scientific (TMO) Investor Presentation – Slideshow” on May 25, 2018. Seekingalpha.com‘s article titled: “Tracking Al Gore’s Generation Investment Management Portfolio – Q1 2018 Update” and published on May 26, 2018 is yet another important article.

Thermo Fisher Scientific Inc. (NYSE:TMO) Ratings Coverage

Among 9 analysts covering Thermo Fisher (NYSE:TMO), 8 have Buy rating, 0 Sell and 1 Hold. Therefore 89% are positive. Thermo Fisher had 12 analyst reports since January 3, 2018 according to SRatingsIntel. As per Thursday, February 1, the company rating was maintained by Morgan Stanley. The firm has “Overweight” rating by Morgan Stanley given on Thursday, April 26. The firm has “Buy” rating by Bank of America given on Thursday, February 1. The stock of Thermo Fisher Scientific Inc. (NYSE:TMO) has “Hold” rating given on Thursday, February 1 by Jefferies. On Wednesday, January 31 the stock rating was maintained by Cowen & Co with “Buy”. The rating was maintained by Robert W. Baird with “Buy” on Thursday, January 18. On Wednesday, April 11 the stock rating was maintained by Morgan Stanley with “Overweight”. The rating was maintained by Barclays Capital with “Overweight” on Thursday, February 1. Robert W. Baird maintained Thermo Fisher Scientific Inc. (NYSE:TMO) rating on Wednesday, January 31. Robert W. Baird has “Buy” rating and $236.0 target. As per Wednesday, January 3, the company rating was initiated by Evercore.

Thermo Fisher Scientific Inc. (NYSE:TMO) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter: